Tyra Biosciences Stock Performance
| TYRA Stock | USD 32.34 1.26 4.05% |
Tyra Biosciences holds a performance score of 21 on a scale of zero to a hundred. The entity has a beta of -0.55, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Tyra Biosciences are expected to decrease at a much lower rate. During the bear market, Tyra Biosciences is likely to outperform the market. Use Tyra Biosciences expected short fall, and the relationship between the value at risk and daily balance of power , to analyze future returns on Tyra Biosciences.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Tyra Biosciences are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Tyra Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 59 M | |
| Total Cashflows From Investing Activities | -98.4 M |
Tyra Biosciences Relative Risk vs. Return Landscape
If you would invest 1,584 in Tyra Biosciences on October 31, 2025 and sell it today you would earn a total of 1,650 from holding Tyra Biosciences or generate 104.17% return on investment over 90 days. Tyra Biosciences is currently generating 1.2744% in daily expected returns and assumes 4.6588% risk (volatility on return distribution) over the 90 days horizon. In different words, 41% of stocks are less volatile than Tyra, and 75% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tyra Biosciences Target Price Odds to finish over Current Price
The tendency of Tyra Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 32.34 | 90 days | 32.34 | nearly 4.66 |
Based on a normal probability distribution, the odds of Tyra Biosciences to move above the current price in 90 days from now is nearly 4.66 (This Tyra Biosciences probability density function shows the probability of Tyra Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Tyra Biosciences has a beta of -0.55. This usually implies as returns on the benchmark increase, returns on holding Tyra Biosciences are expected to decrease at a much lower rate. During a bear market, however, Tyra Biosciences is likely to outperform the market. Moreover Tyra Biosciences has an alpha of 1.2924, implying that it can generate a 1.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Tyra Biosciences Price Density |
| Price |
Predictive Modules for Tyra Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tyra Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tyra Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Tyra Biosciences is not an exception. The market had few large corrections towards the Tyra Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tyra Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tyra Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.29 | |
β | Beta against Dow Jones | -0.55 | |
σ | Overall volatility | 5.39 | |
Ir | Information ratio | 0.26 |
Tyra Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tyra Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tyra Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Tyra Biosciences appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (86.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tyra Biosciences currently holds about 275.11 M in cash with (69.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.61. | |
| Over 97.0% of the company shares are owned by institutional investors |
Tyra Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tyra Stock often depends not only on the future outlook of the current and potential Tyra Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tyra Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 57.2 M | |
| Cash And Short Term Investments | 341.4 M |
Tyra Biosciences Fundamentals Growth
Tyra Stock prices reflect investors' perceptions of the future prospects and financial health of Tyra Biosciences, and Tyra Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tyra Stock performance.
| Return On Equity | -0.35 | |||
| Return On Asset | -0.23 | |||
| Current Valuation | 1.41 B | |||
| Shares Outstanding | 53.37 M | |||
| Price To Earning | (3.33) X | |||
| Price To Book | 5.97 X | |||
| EBITDA | (103.66 M) | |||
| Cash And Equivalents | 275.11 M | |||
| Cash Per Share | 6.61 X | |||
| Total Debt | 6.22 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 5.26 X | |||
| Cash Flow From Operations | (69.77 M) | |||
| Earnings Per Share | (1.88) X | |||
| Total Asset | 363.56 M | |||
| Retained Earnings | (251.31 M) | |||
About Tyra Biosciences Performance
By analyzing Tyra Biosciences' fundamental ratios, stakeholders can gain valuable insights into Tyra Biosciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tyra Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tyra Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California. Tyra Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 25 people.Things to note about Tyra Biosciences performance evaluation
Checking the ongoing alerts about Tyra Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tyra Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tyra Biosciences appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (86.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tyra Biosciences currently holds about 275.11 M in cash with (69.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.61. | |
| Over 97.0% of the company shares are owned by institutional investors |
- Analyzing Tyra Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tyra Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Tyra Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tyra Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tyra Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tyra Biosciences' stock. These opinions can provide insight into Tyra Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Tyra Stock analysis
When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |